A detailed history of Great West Life Assurance CO transactions in Veracyte, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 8,198 shares of VCYT stock, worth $176,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,198
Previous 7,668 6.91%
Holding current value
$176,502
Previous $210,000 13.33%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$21.0 - $29.1 $11,130 - $15,423
530 Added 6.91%
8,198 $182,000
Q4 2023

Feb 13, 2024

SELL
$19.72 - $28.68 $9,978 - $14,512
-506 Reduced 6.19%
7,668 $210,000
Q3 2023

Nov 14, 2023

BUY
$22.33 - $29.92 $71,456 - $95,744
3,200 Added 64.33%
8,174 $183,000
Q2 2023

Aug 10, 2023

SELL
$20.96 - $26.99 $8,446 - $10,876
-403 Reduced 7.49%
4,974 $127,000
Q1 2023

May 12, 2023

BUY
$20.58 - $27.89 $3,478 - $4,713
169 Added 3.25%
5,377 $120,000
Q4 2022

Feb 10, 2023

BUY
$15.31 - $29.94 $5,833 - $11,407
381 Added 7.89%
5,208 $124,000
Q3 2022

Nov 01, 2022

BUY
$16.58 - $27.9 $80,031 - $134,673
4,827 New
4,827 $80,000
Q2 2022

Aug 09, 2022

BUY
$15.45 - $29.52 $3,862 - $7,380
250 Added 5.76%
4,593 $91,000
Q1 2022

May 12, 2022

BUY
$21.94 - $42.51 $4,739 - $9,182
216 Added 5.23%
4,343 $127,000
Q4 2021

Feb 14, 2022

BUY
$36.09 - $53.79 $7,614 - $11,349
211 Added 5.39%
4,127 $170,000
Q1 2021

May 17, 2021

BUY
$44.47 - $81.38 $16,053 - $29,378
361 Added 10.15%
3,916 $209,000
Q3 2020

Nov 17, 2020

SELL
$26.73 - $35.67 $80,216 - $107,045
-3,001 Reduced 45.77%
3,555 $115,000
Q3 2020

Nov 13, 2020

BUY
$26.73 - $35.67 $80,216 - $107,045
3,001 Added 84.42%
6,556 $213,000
Q4 2019

Feb 11, 2020

BUY
$20.78 - $29.99 $73,872 - $106,614
3,555 New
3,555 $99,000
Q3 2019

Oct 25, 2019

SELL
$23.87 - $30.93 $89,679 - $116,204
-3,757 Closed
0 $0
Q2 2019

Jul 31, 2019

BUY
$22.1 - $28.56 $83,029 - $107,299
3,757 New
3,757 $0

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $1.54B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.